Company / Operating Cash Flow
Omega Healthcare Investors Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$878.6M
FY2025
5-year range
$553.7M / $878.6M
FY2021-FY2025
Trend
+17.2%
vs FY2024
Sector context
#34 of 143
Real Estate
What the data says
Omega Healthcare Investors's operating cash flow of $879M is higher than 76% of companies in the Real Estate sector (FY2025). Operating Cash Flow has increased for 5 consecutive years, from $499M in FY2020 to $879M in FY2025.
Based on SEC 10-K filings.
$879M in FY2025 with a 5-year CAGR of +12.0%. Top quartile in the Real Estate sector.
Improved from $722M to $879M over the past 2 years.
Real Estate sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +7.4%
- 5-Year CAGR
- +12.0%
- 10-Year CAGR
- -
Sector benchmark
+29.2% above sector average
Key checks
Key Insights
- Omega Healthcare Investors's operating cash flow has grown for 5 consecutive years.
- 5-year CAGR of +12.0%, indicating consistent growth.
- In FY2025, operating cash flow increased 17.2% year-over-year.
- Ranks #34 out of 143 companies in the Real Estate sector.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- Strong profit margin: 21.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $878.6M | +17.2% |
| FY2024 | $749.4M | +3.8% |
| FY2023 | $722.1M | +2.0% |
| FY2022 | $708.3M | +27.9% |
| FY2021 | $553.7M | +10.9% |
| FY2020 | $499.4M | -9.8% |
| FY2019 | $553.7M | +10.9% |
| FY2018 | $499.4M | -13.6% |
| FY2017 | $577.9M | -7.5% |
| FY2016 | $624.8M | +39.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026